Scavuzzo M C, Rocchi V, Fattori B, Ambrogi F, Carpi A, Ruffoli R, Manganelli S, Giannessi F
Dipartimento di Morfologia Umana e Biologia Applicata, Università di Pisa, Via Roma 67, 56126 Pisa, Italy.
Biomed Pharmacother. 2003 Oct;57(8):366-71. doi: 10.1016/s0753-3322(03)00097-0.
Allergic rhinitis is regulated by the local production and release of several cytokines. The levels of Th2 cytokines IL-4, IL-6, IL-10 and the Th1 cytokine IFN-gamma were studied in nasal mucus from 30 subjects with allergic rhinitis and 45 non-atopic healthy controls. In this study a sampling technique for collecting nasal mucus, well tolerated by the subjects and with a minimal stimulation of the mucosa, was performed. The cytokine concentrations in nasal mucus samples were detected and quantitated by a new paramagnetic particle-based immunofluorescent assay system more sensitive than the conventional ELISA techniques. The new technique showed reliable values of the measured parameters. The nasal mucus from allergic patients contained significantly higher concentrations of IL-4 (25.5 +/- 3.6 pg/ml; P < 0.001) and IL-10 (1300 +/- 190 pg/ml; P < 0.05) compared to the nasal mucus from control subjects (15.2 +/- 2.3 and 532 +/- 28 pg/ml, respectively, for IL-4 and IL-10). No significant modification in IFN-gamma levels of allergic patients was found when compared to control group (respectively, 19.9 +/- 3.3 vs. 25.7 +/- 5.1 pg/ml; P > 0.05). Moreover, the allergic patients showed lower levels of IL-6 concentrations in the nasal mucus compared to control subjects (64.8 +/- 9.1 vs. 129.0 +/- 18.1 pg/ml; P = 0.0099). These data can be interpreted by the hypothesis that in response to environmental allergens there is a preferential Th2 polarity by activated CD4+ T cells and that the cytokines IL-6 and IL-10 have, respectively, an important anti-inflammatory and counterregulatory action in the pathogenesis of allergic rhinitis.
变应性鼻炎受多种细胞因子在局部的产生和释放调控。对30例变应性鼻炎患者和45例非特应性健康对照者的鼻黏液中Th2细胞因子白细胞介素-4(IL-4)、白细胞介素-6(IL-6)、白细胞介素-10及Th1细胞因子干扰素-γ(IFN-γ)水平进行了研究。本研究采用了一种采集鼻黏液的采样技术,受试者耐受性良好,对黏膜的刺激最小。通过一种基于顺磁性颗粒的新型免疫荧光检测系统检测并定量鼻黏液样本中的细胞因子浓度,该系统比传统酶联免疫吸附测定(ELISA)技术更灵敏。新技术显示所测参数值可靠。与对照受试者的鼻黏液相比(IL-4和IL-10分别为15.2±2.3和532±28 pg/ml),变应性患者的鼻黏液中IL-4(25.5±3.6 pg/ml;P<0.001)和IL-10(1300±190 pg/ml;P<0.05)浓度显著更高。与对照组相比,变应性患者的IFN-γ水平未发现显著变化(分别为19.9±3.3与25.7±5.1 pg/ml;P>0.05)。此外,与对照受试者相比,变应性患者鼻黏液中的IL-6浓度较低(64.8±9.1与129.0±18.1 pg/ml;P = 0.0099)。这些数据可以通过以下假设来解释:在对环境变应原的反应中,活化的CD4+T细胞存在优先的Th2极化,并且细胞因子IL-6和IL-10在变应性鼻炎的发病机制中分别具有重要的抗炎和反调节作用。